Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Kennedy pathway refers to the biosynthetic routes responsible for the formation of the two most abundant mammalian membrane phospholipids, phosphatidylcholine and phosphatidylethanolamine[1][2][3][4][7]. It comprises two parallel branches: the CDP-choline pathway (synthesizing phosphatidylcholine) and the CDP-ethanolamine pathway (synthesizing phosphatidylethanolamine). Both begin with phosphorylation of choline or ethanolamine, followed by conversion to CDP-activated intermediates and final transfer to diacylglycerol, catalyzed by enzymes including choline kinase, ethanolamine kinase, cytidylyltransferases (CCT, ECT), and phosphotransferases (CEPT, EPT)[1][3][4][7]. The pathway is essential for cell membrane synthesis, maintenance, and repair, and defects in key enzymes are linked to rare but severe inherited diseases[1][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Kennedy pathway for phospholipid synthesis.